Life Sciences BPO market comprises of contracting of non-primary business activities and functions to a third-party provider. The global life sciences BPO market is driven by factors such as increasing cost of research and development (R&D), growing price pressures, and increase in investments by pharmaceutical and medical devices companies in emerging economies such as India, China, Brazil, and South Africa. Furthermore, increasing prevalence of Covid-19 and subsequent R&D activities is also expected to propel growth of the global life sciences BPO market over the forecast period.
Key features of the study:
- This report provides in-depth analysis of the Global Life Sciences BPO market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the Global Life Sciences BPO market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include, Accenture, Plc., Boehringer Ingelheim GmbH, Charles River Laboratories International, Inc., Cognizant Technology Solutions, Covance, Inc., DSM, Fareva, ICON, Plc, Infosys, Catalent, Inc., Genpact Limited, Health Decisions, Inc., and ProMab Biotechnologies, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The Global Life Sciences BPO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Life Sciences BPO market
Detailed Segmentation:
- Global Life Sciences BPO Market, By Service Type:
- CMO
- API Manufacturing
- Final dosage form manufacturing
- Packaging
- CRO
- Drug Discovery
- Preclinical studies
- Early Phase I - IIa
- Phase IIa - III
- Phase IIIb - IV
- Medical writing
- Pharmcovigilance
- Monitoring
- Clinical Data Management
- Regulatory services
- Bio-statistics
- Site management
- Protocol development
- Others
- Global Life Sciences BPO Market, By Region:
- North America
- By Service Type:
- CMO
- API Manufacturing
- Final dosage form manufacturing
- Packaging
- CRO
- Drug Discovery
- Preclinical studies
- Early Phase I - IIa
- Phase IIa - III
- Phase IIIb - IV
- Medical writing
- Pharmcovigilance
- Monitoring
- Clinical Data Management
- Regulatory services
- Bio-statistics
- Site management
- Protocol development
- Others
- By Country
- Latin America
- By Service Type:
- CMO
- API Manufacturing
- Final dosage form manufacturing
- Packaging
- CRO
- Drug Discovery
- Preclinical studies
- Early Phase I - IIa
- Phase IIa - III
- Phase IIIb - IV
- Medical writing
- Pharmcovigilance
- Monitoring
- Clinical Data Management
- Regulatory services
- Bio-statistics
- Site management
- Protocol development
- Others
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Service Type:
- CMO
- API Manufacturing
- Final dosage form manufacturing
- Packaging
- CRO
- Drug Discovery
- Preclinical studies
- Early Phase I - IIa
- Phase IIa - III
- Phase IIIb - IV
- Medical writing
- Pharmcovigilance
- Monitoring
- Clinical Data Management
- Regulatory services
- Bio-statistics
- Site management
- Protocol development
- Others
- By Country
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- By Service Type:
- CMO
- API Manufacturing
- Final dosage form manufacturing
- Packaging
- CRO
- Drug Discovery
- Preclinical studies
- Early Phase I - IIa
- Phase IIa - III
- Phase IIIb - IV
- Medical writing
- Pharmcovigilance
- Monitoring
- Clinical Data Management
- Regulatory services
- Bio-statistics
- Site management
- Protocol development
- Others
- By Country
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Service Type:
- CMO
- API Manufacturing
- Final dosage form manufacturing
- Packaging
- CRO
- Drug Discovery
- Preclinical studies
- Early Phase I - IIa
- Phase IIa - III
- Phase IIIb - IV
- Medical writing
- Pharmcovigilance
- Monitoring
- Clinical Data Management
- Regulatory services
- Bio-statistics
- Site management
- Protocol development
- Others
- By Country
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- By Service Type:
- CMO
- API Manufacturing
- Final dosage form manufacturing
- Packaging
- CRO
- Drug Discovery
- Preclinical studies
- Early Phase I - IIa
- Phase IIa - III
- Phase IIIb - IV
- Medical writing
- Pharmcovigilance
- Monitoring
- Clinical Data Management
- Regulatory services
- Bio-statistics
- Site management
- Protocol development
- Others
- By Country
- North Africa
- Central Africa
- South Africa
- Company Profiles
- Accenture, Plc. *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Boehringer Ingelheim GmbH
- Charles River Laboratories International, Inc.
- Cognizant Technology Solutions
- Covance, Inc.
- DSM
- Fareva
- ICON, Plc
- Infosys
- Catalent, Inc.
- Genpact Limited
- Health Decisions, Inc.
- Health Decisions, Inc.
- “*” marked represents similar segmentation in other categories in the respective section.
